Philippines' healthcare spend to grow 9.2% to US$36b in 2026 | Healthcare Asia Magazine
, Singapore
165 views

Philippines' healthcare spend to grow 9.2% to US$36b in 2026

Thanks to higher government expenditure.

It has been noted that generic drugmakers will be the primary beneficiaries of the Philippine government's investment into healthcare.

According to a research note from BMI Research, while the expansion of universal healthcare is a positive for the broader pharmaceutical sector, the specific target of President Rodrigo Duterte's 2017 budget and other public health initiatives are on expanding healthcare access to low-income Filipinos.

This will grow a patient segment that, given constraints on affordability, will demand for low-cost pharmaceuticals. Such opportunities will spur greater investment from both multinational drugmakers with strong generic portfolios and Indian pharmaceutical firms, intensifying the level of competition.

Here's more from BMI Research:

The outlook for healthcare access in the Philippines will continue to improve as the government's commitment to the sector remains unchanged under President Rodrigo Duterte. Aligning with our view that Duterte will take a less controversial stance with regards to healthcare policy , the President allocated 20% of the PHP5b (USD100m) donation from the Philippine Amusement and Gaming Corporation towards funding medicine costs for low income Filipinos.

This initiative will be managed by the Department of Social Welfare and Development in coordination with the Department of Health. According to officials, social workers can provide funding for medicines lower than PHP5,000 (USD100) and up to PHP25,000 (USD500) with an approval from the field office. This reinforces our expectations for healthcare expenditure in the Philippines to grow steadily through to 2026, rising from PHP722b (USD15b) in 2016 to PHP1,743b (USD36b).

This is a strong 10-year compound annual growth rate of 9.2% in local currency and US dollar terms. Growth will be driven primarily from government spending due to the continued expansion of universal healthcare over the forecast period which will see its contribution to total healthcare spending rise from 36% in 2016 to 44% by 2026.

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

KFSHRC Saudi bertumpu pada inovasi untuk mentransformasi layanan kesehatan

Rumah sakit ini mempercepat adopsi teknologi baru untuk memposisikan dirinya sebagai pemimpin global di bidang kedokteran.

Angkor Hospital merencanakan pusat trauma untuk anak-anak

Fasilitas ini akan memiliki ICU, ruang gawat darurat, ruang operasi, dan bangsal bedah.

Bali International Hospital dan HK Asia Medical mendirikan pusat jantung baru

Fasilitas ini akan menawarkan diagnostik, operasi invasif minimal, dan perawatan pasca operasi.

Pasar pencitraan medis Indonesia diproyeksikan tumbuh 6,12% CAGR hingga 2030

Salah satu pendorong utama adalah peningkatan inisiatif yang dipimpin pemerintah.

Rumah Sakit Pusat Kamboja beralih ke adopsi teknologi untuk meningkatkan layanan jantung

Salah satu teknologi kunci mereka adalah mesin ECMO untuk mendukung hidup yang berkepanjangan dalam kondisi kritis.

Ekspor farmasi Indonesia diperkirakan tumbuh 7,7% CAGR hingga 2028

Berkat upaya pemerintah dan aturan investasi baru untuk meningkatkan produksi domestik.

Jepang dan Indonesia tandatangani MoU untuk pelatihan perawat dan pekerja perawatan

Kemitraan ini bertujuan membimbing tenaga kesehatan Indonesia agar memenuhi standar tenaga kerja profesional Jepang.

Pusat gigi nasional Singapura berada di garda terdepan layanan gigi digital

Teknologi pemindaian intraoralnya menggantikan metode pencetakan gigi tradisional.

Inovasi medis global dan solusi berbasis AI menjadi sorotan

Medical Taiwan 2024 menghadirkan 280 peserta dari 10 negara dan mendorong integrasi teknologi dalam layanan kesehatan.